SKI Market

Indian Indices

Sensex

83,817.69 78.56
( 0.09%)

Global Indices

Nasdaq

49,515.77 253.77
(0.52%)

Dow Jones

6,903.45 -35.36
(-0.51%)

Hang Seng

54,378.12 -342.54
(-0.63%)

Nikkei 225

10,444.71 130.12
(1.26%)

Forex

USD-INR

90.33 -1.29
(-1.40%)

EUR-INR

106.65 -1.90
(-1.75%)

GBP-INR

123.60 -1.74
(-1.39%)

JPY-INR

0.58 -0.01
(-1.94%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Astal Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

512600

INE307N01014

76.88845

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

35.01

347.31

EPS(TTM)

Face Value()

Div & Yield %

2.35

Back

LTIMindtree bags Rs 3000 cr Insight 2.0 project from CBDT

Jan 16,2026

LTIMindtree announced that it has been awarded the Insight 2.0 project from the Central Board of Direct Taxes (CBDT) to build an AI‑powered program for the modernization of India's national tax analytics platform. Valued at around Rs 3000 crore, this 7-year mandate reinforces LTIMindtree's leadership in enabling digital transformation leveraging advanced digital architecture and data analytics to deliver real-time insights for policymakers.

83,817.69 78.56 ( 0.09%)

49,515.77 253.77 (0.52%)

6,903.45 -35.36 (-0.51%)

54,378.12 -342.54 (-0.63%)

10,444.71 130.12 (1.26%)

90.33 -1.29 (-1.40%)

106.65 -1.90 (-1.75%)

123.60 -1.74 (-1.39%)

0.58 -0.01 (-1.94%)